Business and Finance Business and Finance
Sun, March 2, 2025
[ Sun, Mar 02nd ] - NDTV
7 Yoga Asanas For PCOD
[ Sun, Mar 02nd ] - MSN
The BEST Wendy's Breakfast Meal
Sat, March 1, 2025

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript


Published on 2025-03-01 22:00:58 - MSN
  Print publication without navigation

  • Q4 2024 Earnings Call Transcript February 28, 2025 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.31. Operator: Greetings, and welcome to the Fulgent Genetics,

The article provides a transcript of Fulgent Genetics Inc.'s Q4 2024 earnings call, where the company discussed its financial performance and strategic updates. Fulgent Genetics reported a revenue of $100.2 million for the quarter, a significant increase from the previous year, driven by growth in their core genetic testing business and expansion into new markets. Key points included the launch of new diagnostic tests, progress in their pharmaceutical services, and an increase in their laboratory-developed tests (LDTs). The company also highlighted their efforts in enhancing their technology platform, which has improved turnaround times and testing capabilities. Additionally, Fulgent discussed their strategic investments in research and development, aiming to broaden their product offerings and address unmet medical needs. The call also touched on the company's outlook for 2024, with expectations of continued growth and profitability, supported by a robust pipeline of innovative tests and services.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/general/fulgent-genetics-inc-nasdaq-flgt-q4-2024-earnings-call-transcript/ar-AA1A2VZN ]

Similar Business and Finance Articles